EP 0533770 A1 19930331 - NOVEL TREATMENT.
Title (en)
NOVEL TREATMENT.
Title (de)
NEUE BEHANDLUNG.
Title (fr)
NOUVEAU TRAITEMENT.
Publication
Application
Priority
- GB 9013910 A 19900622
- GB 9018676 A 19900824
Abstract (en)
[origin: WO9200102A1] Co-administration of a histamine H2-receptor antagonist and antacid for the treatment of gastric disorders.
Abstract (fr)
Administration en combinaison d'un antagoniste de récepteur-H2 d'histamine et d'un antiacide destinés au traitement de troubles gastriques.
IPC 1-7
IPC 8 full level
A61K 31/13 (2006.01); A61K 31/34 (2006.01); A61K 31/415 (2006.01); A61K 31/425 (2006.01); A61K 33/00 (2006.01); A61K 33/08 (2006.01); A61K 33/10 (2006.01); A61K 33/12 (2006.01); A61K 33/24 (2006.01); A61K 33/42 (2006.01); A61K 45/06 (2006.01); A61P 1/00 (2006.01); A61P 1/04 (2006.01)
CPC (source: EP KR)
A61K 33/00 (2013.01 - EP); A61K 33/08 (2013.01 - EP); A61K 33/10 (2013.01 - EP); A61K 33/12 (2013.01 - EP); A61K 33/245 (2013.01 - EP); A61K 33/42 (2013.01 - EP); A61K 45/06 (2013.01 - KR); A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP)
Citation (search report)
See references of WO 9200102A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU NL SE
DOCDB simple family (publication)
WO 9200102 A1 19920109; AU 7981391 A 19920123; CA 2085873 A1 19911223; EP 0533770 A1 19930331; IE 912133 A1 19920101; JP H05507695 A 19931104; KR 930701196 A 19930611
DOCDB simple family (application)
GB 9100953 W 19910613; AU 7981391 A 19910613; CA 2085873 A 19910613; EP 91911107 A 19910613; IE 213391 A 19910620; JP 51056791 A 19910613; KR 920703296 A 19921221